Dapagliflozin reduces albuminuria in CKD patients with or without diabetes: Lancet study Medha7 Oct 2021 5:00 AM GMTUSA: A prespecified analysis from the DAPA-CKD trial has found that the SGLT2 inhibitor dapagliflozin significantly reduces albuminuria in patients...
Dapagliflozin, saxagliptin combo bests glimepiride for controlling blood sugar in diabetes: Study Medha30 Sep 2021 7:15 AM GMTUSA: The combo of dapagliflozin+saxagliptin+metformin was associated with better blood sugar control, efficacy, and metabolic benefits than...
Dapagliflozin relieves symptoms, physical limitations in HFpEF patients: PRESERVED-HF trial Medha25 Sep 2021 3:30 AM GMTUSA: Dapagliflozin improves physical limitations and symptoms in patients having heart failure with preserved ejection fraction (HFpEF) within a...
Dapagliflozin reduces risk of sudden cardiac death, ventricular arrhythmia in HFrEF patients: Study Medha6 Sep 2021 3:30 AM GMTUK: A recent study has found that dapagliflozin when added to conventional therapy in HFrEF patients reduces the risk of cardiac arrest, any serious...
NPPA fixes retail price of 19 formulations including Metformin, Dapagliflozin, Details Medical Dialogues Team27 Aug 2021 8:15 AM GMTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, h...
Dapagliflozin a cost-effective adjunct therapy for chronic HFrEF: Study Dr. Shravani Dali21 Aug 2021 12:45 AM GMTDapagliflozin is an economical adjunct therapy to usual care for the management of chronic heart failure and reduced ejection fraction (HFrEF),...
Dapagliflozin reduces risk for hyperkalemia in HFrEF patients treated with MRAs: Study Dr. Shravani Dali20 Aug 2021 3:30 AM GMTDapagliflozin Reduces Hyperkalemia Risk in Heart Failure and reduced ejection fraction (HFrEF) in patients treated with mineralocorticoid receptor...
NPPA approves prices of 25 new drugs including Dapagliflozin, Metformin, Details Medical Dialogues Team7 Aug 2021 11:18 AM GMTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) approved retail pricing for 25 new drugs under the Drug Price Control Order (DPCO)...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Lupin Medical Dialogues Team29 July 2021 12:51 PM GMTNew Delhi: With the popular antidiabetic drug, Dapagliflozin, going off-patent, the National Pharmaceutical Pricing Authority (NPPA) panel, giving bene...
Setback to AstraZeneca: Delhi HC rejects plea against 9 pharma firms over Dapagliflozin Medical Dialogues Team26 July 2021 10:42 AM GMTNew Delhi: In a major setback to AstraZeneca and its Indian subsidiary ,the Delhi High Court has dismissed AstraZeneca's plea against nine generic phar...
SGLT2 inhibitor dapagliflozin safe and effective in patients with advanced kidney disease: Study Hina Zahid21 July 2021 12:45 PM GMTThe effects of dapagliflozin in patients with stage 4 CKD are similar to effects in patients with mild to moderate CKD. USA: The benefits of SGLT2...
NPPA fixes price of 14 formulations including Diabetes drugs and antibiotics, Details Medical Dialogues Team20 July 2021 8:01 AM GMTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, h...
